Back to Search
Start Over
Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients.
- Source :
-
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2018 Oct; Vol. 45 (10), pp. 1002-1009. Date of Electronic Publication: 2018 Jul 26. - Publication Year :
- 2018
-
Abstract
- Regulatory T (Treg) cells are critical suppressors of inflammation and are thought to exert mainly deleterious effects in cancers. In colorectal cancer (CRC), Foxp3 <superscript>+</superscript> Treg accumulation in tumors was associated with poor prognosis. Hence, we examined the circulating Treg cells in CRC patients. Compared to controls, CRC patients presented mild upregulations in CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells and in the more canonical CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> Foxp3 <superscript>+</superscript> Treg cells in peripheral blood mononuclear cells. Both of these Treg populations could be roughly divided into lymphocyte activation gene 3 negative T cell immunoglobulin and mucin-domain containing-3 negative (LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> ) and LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> subsets. In CRC patients, the LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> subset represented approximately half of CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells and greater than 60% of CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> Foxp3 <superscript>+</superscript> Treg cells, which was significantly more frequent than in healthy controls. Compared to the LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells, the LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells presented considerably higher transforming growth factor-β and slightly higher interleukin (IL)-10 secretion, together with higher cytotoxic T-lymphocyte associated protein 4 and Foxp3 expression levels. Notably, macrophages following incubation with LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells and LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells displayed different characteristics. Macrophages incubated with LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells presented lower expression of major histocompatibility complex class II, CD80, CD86, and tumor necrosis factor-α but higher expression of IL-10, than macrophages incubated with LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> CD4 <superscript>+</superscript> CD25 <superscript>+/hi</superscript> T cells. Together, our investigations demonstrated that CRC patients presented an enrichment of circulating Treg cells, in which the LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> subset exhibited more potent expression of inhibitory molecules, and furthermore, the LAG3 <superscript>+</superscript> TIM3 <superscript>+</superscript> Treg cells could suppress the proinflammatory activation of macrophages more potently than the LAG3 <superscript>-</superscript> TIM3 <superscript>-</superscript> Treg cells.<br /> (© 2018 John Wiley & Sons Australia, Ltd.)
- Subjects :
- Adult
Aged
Case-Control Studies
Cell Proliferation
Female
Humans
Interleukin-10 metabolism
Macrophages metabolism
Male
Middle Aged
Lymphocyte Activation Gene 3 Protein
Antigens, CD metabolism
Colorectal Neoplasms genetics
Colorectal Neoplasms immunology
Gene Expression Regulation, Neoplastic
Hepatitis A Virus Cellular Receptor 2 metabolism
Macrophages immunology
T-Lymphocytes, Regulatory cytology
Subjects
Details
- Language :
- English
- ISSN :
- 1440-1681
- Volume :
- 45
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Clinical and experimental pharmacology & physiology
- Publication Type :
- Academic Journal
- Accession number :
- 29905955
- Full Text :
- https://doi.org/10.1111/1440-1681.12992